Predicting Heart Failure with Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Inftypes

Circulation: Heart Failure

Volumn 9, Issue 6, 2016, Pages

  Ho, Jennifer E ^a,d   Enserro, Danielle ^e   Brouwers, Frank P ^f   Kizer, Jorge R ^h   Shah, Sanjiv J ⁱ   Psaty, Bruce M ^k,m   Bartz, Traci M ^l   Santhanakrishnan, Rajalakshmi ^b   Lee, Douglas S ^n,o   Chan, Cheeling ^f,j   Liu, Kiang ^f,j   Blaha, Michael J ^p   Hillege, Hans L ^f   Van Der Harst, Pim ^f   Van Gilst, Wiek H ^f   Kop, Willem J ^f,r   Gansevoort, Ron T ^g   Vasan, Ramachandran S ^c,d   Gardin, Julius M ^q   Levy, Daniel ^d   Gottdiener, John S ^i,t   De Boer, Rudolf A ^s   Larson, Martin G ^d,e   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Cardiovascular Medicine Section   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY   (United States)

^e Boston University   (United States)

^f Department of Cardiology ^*  (United States)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁱ Division of Cardiology   (United States)

^j NORTHWESTERN UNIVERSITY   (United States)

^k U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^l UNIVERSITY OF WASHINGTON   (United States)

^m CENTER FOR HEALTH STUDIES   (United States)

ⁿ INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^o UNIVERSITY HEALTH NETWORK   (Canada)

^p JOHNS HOPKINS UNIVERSITY   (United States)

^q HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^r TILBURG UNIVERSITY   (Netherlands)

^s NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^t UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

more..

Author keywords

diastolic heart failure; phenotype; primary prevention; risk factor; systolic heart failure

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART BUNDLE BRANCH BLOCK; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; ST SEGMENT; SYSTOLIC BLOOD PRESSURE; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; DECISION SUPPORT SYSTEM; EPIDEMIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; UNITED STATES; VALIDATION STUDY;

ADULT; AGED; DECISION SUPPORT TECHNIQUES; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; TIME FACTORS; UNITED STATES; VENTRICULAR FUNCTION, LEFT;

EID: 84975873960     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.115.003116     Document Type: Article

References (47)

1. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D, Framingham Heart Study Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002 106 3068 3072
2. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM, Nichol G, Pham M, Piña IL, Trogdon JG, American Heart Association Advocacy Coordinating Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Stroke Council Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 2013 6 606 619. doi: 10.1161/HHF.0b013e318291329a
3. McMurray JJ, Petrie MC, Murdoch DR, Davie AP, Clinical epidemiology of heart failure: public and private health burden. Eur Heart J 1998 19 suppl P P9 16
4. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL, 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013 128 1810 1852. doi: 10.1161/CIR.0b013e31829e8807
5. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD, American Heart Association Strategic Planning Task Force and Statistics Committee Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010 121 586 613. doi: 10.1161/CIRCULATIONAHA.109.192703
6. Schocken DD, Benjamin EJ, Fonarow GC, Krumholz HM, Levy D, Mensah GA, Narula J, Shor ES, Young JB, Hong Y, American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Nursing; American Heart Association Council on High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; Functional Genomics and Translational Biology Interdisciplinary Working Group Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008 117 2544 2565. doi: 10.1161/CIRCULATIONAHA.107.188965
7. Echouffo-Tcheugui JB, Greene SJ, Papadimitriou L, Zannad F, Yancy CW, Gheorghiade M, Butler J, Population risk prediction models for incident heart failure: a systematic review. Circ Heart Fail 2015 8 438 447. doi: 10.1161/CIRCHEARTFAILURE.114.001896
8. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, ESC Committee for Practice Guidelines ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012 33 1787 1847. doi: 10.1093/eurheartj/ehs104
9. Borlaug BA, Redfield MM, Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation 2011 123 2006 13; discussion 2014. doi: 10.1161/CIRCULATIONAHA.110.954388
10. Ho JE, Gona P, Pencina MJ, Tu JV, Austin PC, Vasan RS, Kannel WB, D'Agostino RB, Lee DS, Levy D, Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community. Eur Heart J 2012 33 1734 1741. doi: 10.1093/eurheartj/ehs070
11. Ho JE, Lyass A, Lee DS, Vasan RS, Kannel WB, Larson MG, Levy D, Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail 2013 6 279 286. doi: 10.1161/CIRCHEARTFAILURE.112.972828
12. Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, Hillege HL, van Veldhuisen DJ, van Gilst WH, Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J 2013 34 1424 1431. doi: 10.1093/eurheartj/eht066
13. Dawber TR, Kannel WB, Lyell LP, An approach to longitudinal studies in a community: the Framingham Study. Ann NY Acad Sci 1963 107 539 556
14. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP, An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 1979 110 281 290
15. Psaty BM, Kuller LH, Bild D, Burke GL, Kittner SJ, Mittelmark M, Price TR, Rautaharju PM, Robbins J, Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol 1995 5 270 277
16. Diercks GF, Janssen WM, van Boven AJ, Bak AA, de Jong PE, Crijns HJ, van Gilst WH, Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT]). Am J Cardiol 2000 86 635 638
17. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, Nelson JC, O'Leary D, Saad MF, Shea S, Szklo M, Tracy RP, Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002 156 871 881
18. Gaynor JJ, Feuer EJ, Tan CC, Wu DH, On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc 1993 86 770 778
19. Fine JP, Gray RJ, A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999 94 496 509
20. Kohl M, Plischke M, Leffondré K, Heinze G, PSHREG: a SAS macro for proportional and nonproportional subdistribution hazards regression. Comput Methods Programs Biomed 2015 118 218 233. doi: 10.1016/j.cmpb.2014.11.009
21. Pencina MJ, D'Agostino RB Sr, Song L, Quantifying discrimination of Framingham risk functions with different survival C statistics. Stat Med 2012 31 1543 1553. doi: 10.1002/sim.4508
22. Lunn M, McNeil D, Applying Cox regression to competing risks. Biometrics 1995 51 524 532
23. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014 129 e28 e292. doi: 10.1161/01.cir.0000441139.02102.80
24. Chahal H, Bluemke DA, Wu CO, McClelland R, Liu K, Shea SJ, Burke G, Balfour P, Herrington D, Shi P, Post W, Olson J, Watson KE, Folsom AR, Lima JA, Heart failure risk prediction in the multi-ethnic study of atherosclerosis. Heart 2015 101 58 64. doi: 10.1136/heartjnl-2014-305697
25. Agarwal SK, Chambless LE, Ballantyne CM, Astor B, Bertoni AG, Chang PP, Folsom AR, He M, Hoogeveen RC, Ni H, Quibrera PM, Rosamond WD, Russell SD, Shahar E, Heiss G, Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study. Circ Heart Fail 2012 5 422 429. doi: 10.1161/CIRCHEARTFAILURE.111.964841
26. Kalogeropoulos A, Psaty BM, Vasan RS, Georgiopoulou V, Smith AL, Smith NL, Kritchevsky SB, Wilson PW, Newman AB, Harris TB, Butler J, Cardiovascular Health Study Validation of the health ABC heart failure model for incident heart failure risk prediction: the Cardiovascular Health Study. Circ Heart Fail 2010 3 495 502. doi: 10.1161/CIRCHEARTFAILURE.109.904300
27. Djoussé L, Driver JA, Gaziano JM, Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA 2009 302 394 400. doi: 10.1001/jama.2009.1062
28. Butler J, Kalogeropoulos A, Georgiopoulou V, Belue R, Rodondi N, Garcia M, Bauer DC, Satterfield S, Smith AL, Vaccarino V, Newman AB, Harris TB, Wilson PW, Kritchevsky SB, Health ABC Study Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail 2008 1 125 133. doi: 10.1161/CIRCHEARTFAILURE.108.768457
29. deFilippi CR, de Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, Seliger SL, Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010 304 2494 2502. doi: 10.1001/jama.2010.1708
30. Kannel WB, D'Agostino RB, Silbershatz H, Belanger AJ, Wilson PW, Levy D, Profile for estimating risk of heart failure. Arch Intern Med 1999 159 1197 1204
31. Goyal A, Norton CR, Thomas TN, Davis RL, Butler J, Ashok V, Zhao L, Vaccarino V, Wilson PW, Predictors of incident heart failure in a large insured population: a one million person-year follow-up study. Circ Heart Fail 2010 3 698 705. doi: 10.1161/CIRCHEARTFAILURE.110.938175
32. Wong YW, Thomas L, Sun JL, McMurray JJ, Krum H, Hernandez AF, Rutten GE, Leiter LA, Standl E, Haffner SM, Mazzone T, Martinez FA, Tognoni G, Giles T, Califf RM, Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research study. Circ Heart Fail 2013 6 203 210. doi: 10.1161/CIRCHEARTFAILURE.112.000086
33. Pfister R, Cairns R, Erdmann E, Schneider CA, A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: an analysis of the PROactive study. Int J Cardiol 2013 162 112 116. doi: 10.1016/j.ijcard.2011.05.056
34. Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, Tu JV, Levy D, Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham heart study of the national heart, lung, and blood institute. Circulation 2009 119 3070 3077. doi: 10.1161/CIRCULATIONAHA.108.815944
35. Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA, Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 2005 112 3738 3744. doi: 10.1161/CIRCULATIONAHA.105.561423
36. Paulus WJ, Tschöpe C, A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013 62 263 271. doi: 10.1016/j.jacc.2013.02.092
37. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC, ADHERE Scientific Advisory Committee and Investigators Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006 47 76 84. doi: 10.1016/j.jacc.2005.09.022
38. Zannad F, Huvelle E, Dickstein K, van Veldhuisen DJ, Stellbrink C, Køber L, Cazeau S, Ritter P, Maggioni AP, Ferrari R, Lechat P, Left bundle branch block as a risk factor for progression to heart failure. Eur J Heart Fail 2007 9 7 14. doi: 10.1016/j.ejheart.2006.04.011
39. Drazner MH, The progression of hypertensive heart disease. Circulation 2011 123 327 334. doi: 10.1161/CIRCULATIONAHA.108.845792
40. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP, Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990 81 815 820
41. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 129 25 suppl 2 S49 S73. doi: 10.1161/01.cir.0000437741.48606.98
42. Brouwers FP, van Gilst WH, Damman K, van den Berg MP, Gansevoort RT, Bakker SJ, Hillege HL, van Veldhuisen DJ, van der Harst P, de Boer RA, Clinical risk stratification optimizes value of biomarkers to predict new-onset heart failure in a community-based cohort. Circ Heart Fail 2014 7 723 731. doi: 10.1161/CIRCHEARTFAILURE.114.001185
43. Wannamethee SG, Welsh P, Whincup PH, Lennon L, Papacosta O, Sattar N, N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study. Eur J Heart Fail 2014 16 25 32. doi: 10.1093/eurjhf/hft124
44. Nambi V, Liu X, Chambless LE, de Lemos JA, Virani SS, Agarwal S, Boerwinkle E, Hoogeveen RC, Aguilar D, Astor BC, Srinivas PR, Deswal A, Mosley TH, Coresh J, Folsom AR, Heiss G, Ballantyne CM, Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk-the atherosclerosis risk in communities study. Clin Chem 2013 59 1802 1810. doi: 10.1373/clinchem.2013.203638
45. Smith JG, Newton-Cheh C, Almgren P, Struck J, Morgenthaler NG, Bergmann A, Platonov PG, Hedblad B, Engström G, Wang TJ, Melander O, Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol 2010 56 1712 1719. doi: 10.1016/j.jacc.2010.05.049
46. Ledwidge M, Gallagher J, Conlon C, Tallon E, O'Connell E, Dawkins I, Watson C, O'Hanlon R, Bermingham M, Patle A, Badabhagni MR, Murtagh G, Voon V, Tilson L, Barry M, McDonald L, Maurer B, McDonald K, Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial. JAMA 2013 310 66 74. doi: 10.1001/jama.2013.7588
47. Wang TJ, Levy D, Benjamin EJ, Vasan RS, The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening. Ann Intern Med 2003 138 907 916